ACXP (Acurx Pharmaceuticals) Insider Ownership: 58.34 % (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ACXP Acurx Pharmaceuticals Inc ACXP
37 GF Score
Price $1.44
View Full Analysis

What is Acurx Pharmaceuticals Insider Ownership?

Acurx Pharmaceuticals ACXP +0.70% 37 Insider Ownership is 58.34 % as of Sep. 09, 2026. GuruFocus rates ACXP with a GF Score™ of 37/100.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Acurx Pharmaceuticals's insider ownership is 58.34%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Acurx Pharmaceuticals's Institutional Ownership is 2.89%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Acurx Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 96.80%.

Acurx Pharmaceuticals Insider Ownership Historical Data

* Premium members only.

The historical data trend for Acurx Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acurx Pharmaceuticals Insider Ownership Chart

Acurx Pharmaceuticals Historical Data

The historical data trend for Acurx Pharmaceuticals can be seen below:

2025-03-31 2025-04-30 2025-05-31 2025-06-30 2025-07-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Insider Ownership 11.38 11.38 10.68 10.68 8.46 98.46 58.34 58.34 58.34 58.34
ACXP
37GF Score
Acurx Pharmaceuticals Inc ACXP
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acurx Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 58.34 % mean?
Acurx Pharmaceuticals (ACXP) has a Insider Ownership of 58.34 % as of Sep. 09, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Acurx Pharmaceuticals and its competitors.
Is Acurx Pharmaceuticals' Insider Ownership too high?
Acurx Pharmaceuticals' current Insider Ownership is 58.34 %. Overall, Acurx Pharmaceuticals has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Acurx Pharmaceuticals' Insider Ownership compare to ENVB and HCWB?
Acurx Pharmaceuticals' Insider Ownership of 58.34 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Acurx Pharmaceuticals and its competitors. Acurx Pharmaceuticals's current Insider Ownership is 58.34 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acurx Pharmaceuticals stock overvalued right now?
Acurx Pharmaceuticals (ACXP) has a current Insider Ownership of 58.34 %. The current Insider Ownership is 58.34 %. Acurx Pharmaceuticals' overall GF Score™ is 37/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Acurx Pharmaceuticals (ACXP), the current Insider Ownership is 58.34 % as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acurx Pharmaceuticals Business Description

Address 259 Liberty Avenue, Staten Island, NY, USA, 10305
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.
37GF Score

Get the complete analysis for ACXP

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.44
Price